Advertisement
COGT vs REPL
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and REPL is a StrongBuy.
COGT's RSI Indicator recovers from oversold territory
The RSI Oscillator for COGT moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 24 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on COGT as a result. In 78 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for COGT just turned positive on October 19, 2026. Looking at past instances where COGT's MACD turned positive, the stock continued to rise in 37 of 47 cases over the following month. The odds of a continued upward trend are 79%.
Following a +4.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where COGT advanced for three days, in 233 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
COGT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 50-day moving average for COGT moved below the 200-day moving average on September 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COGT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for COGT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. COGT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.618) is normal, around the industry mean (2.973). P/E Ratio (-14.495) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
REPL's RSI Oscillator climbs out of oversold territory
The RSI Indicator for REPL moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 42 similar instances when the indicator left oversold territory. In 37 of the 42 cases the stock moved higher. This puts the odds of a move higher at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 59 cases where REPL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +4.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where REPL advanced for three days, in 184 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
REPL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on REPL as a result. In 69 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for REPL turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 42 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
REPL moved below its 50-day moving average on October 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for REPL crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where REPL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for REPL entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. REPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.693) is normal, around the industry mean (2.973). P/E Ratio (-3.806) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. REPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
COGT | REPL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 29 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 47 | 34 | |
P/E GROWTH RATING 1..100 | 22 | 58 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
COGT's Valuation (70) in the Miscellaneous industry is in the same range as REPL (77) in the Biotechnology industry. This means that COGT’s stock grew similarly to REPL’s over the last 12 months.
COGT's Profit vs Risk Rating (29) in the Miscellaneous industry is significantly better than the same rating for REPL (100) in the Biotechnology industry. This means that COGT’s stock grew significantly faster than REPL’s over the last 12 months.
COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as REPL (99) in the Biotechnology industry. This means that COGT’s stock grew similarly to REPL’s over the last 12 months.
REPL's Price Growth Rating (34) in the Biotechnology industry is in the same range as COGT (47) in the Miscellaneous industry. This means that REPL’s stock grew similarly to COGT’s over the last 12 months.
COGT's P/E Growth Rating (22) in the Miscellaneous industry is somewhat better than the same rating for REPL (58) in the Biotechnology industry. This means that COGT’s stock grew somewhat faster than REPL’s over the last 12 months.
| COGT | REPL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 85% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 84% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 83% |
| Advances ODDS (%) | 2 days ago 84% | 1 day ago 75% |
| Declines ODDS (%) | 10 days ago 81% | 9 days ago 84% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COGT’s FA Score shows that 2 FA rating(s) are green while REPL’s FA Score has 0 green FA rating(s).
- COGT’s FA Score: 2 green, 3 red.
- REPL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COGT’s TA Score shows that 5 TA indicator(s) are bullish while REPL’s TA Score has 4 bullish TA indicator(s).
- COGT’s TA Score: 5 bullish, 4 bearish.
- REPL’s TA Score: 4 bullish, 6 bearish.
Price Growth
COGT (@Biotechnology) experienced а +6.10% price change this week, while REPL (@Biotechnology) price change was +2.04% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.17%. For the same industry, the average monthly price growth was -18.21%, and the average quarterly price growth was -15.24%.
Reported Earning Dates
COGT is expected to report earnings on Nov 06, 2026.
REPL is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-1.17% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
COGT and
Correlation & Price change
A.I.dvisor indicates that over the last year, COGT has been closely correlated with DMRA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if COGT jumps, then DMRA could also see price increases.
| Ticker / NAME | Correlation To COGT | 1D Price Change % | ||
|---|---|---|---|---|
| COGT | 100% | -0.38% | ||
| DMRA - COGT | 75% Closely correlated | +0.84% | ||
| ENGN - COGT | 47% Loosely correlated | -3.07% | ||
| REPL - COGT | 42% Loosely correlated | +2.30% | ||
| MLYS - COGT | 42% Loosely correlated | +1.75% | ||
| VERA - COGT | 40% Loosely correlated | -6.89% | ||
More | ||||
REPL and
Correlation & Price change
A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.
| Ticker / NAME | Correlation To REPL | 1D Price Change % | ||
|---|---|---|---|---|
| REPL | 100% | +2.30% | ||
| IMNN - REPL | 57% Loosely correlated | +5.04% | ||
| SNDX - REPL | 49% Loosely correlated | +3.19% | ||
| KYMR - REPL | 45% Loosely correlated | -1.58% | ||
| NRIX - REPL | 43% Loosely correlated | -1.96% | ||
| ZYME - REPL | 42% Loosely correlated | +1.16% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| URE | 63.53 | 1.49 | +2.40% |
| ProShares Ultra Real Estate (URE) | |||
| EAGG | 46.01 | 0.38 | +0.83% |
| iShares ESG Aware US Aggregate Bond ETF (EAGG) | |||
| ADVE | 44.03 | -0.37 | -0.82% |
| Matthews Asia Dividend Active ETF (ADVE) | |||
| DWLD | 44.82 | -0.47 | -1.04% |
| Davis Select Worldwide ETF (DWLD) | |||
| CNYA | 31.18 | -0.65 | -2.04% |
| iShares MSCI China A ETF (CNYA) | |||